Medicine and Dentistry
Patient
80%
Alzheimer's Disease
68%
Parkinson's Disease
39%
Motor Cortex
29%
Stimulation
29%
Dementia
21%
Progressive Supranuclear Palsy
21%
Frailty
21%
Electrical Brain Stimulation
18%
Comprehension
17%
Health
16%
Senescence
16%
Systematic Review
15%
Inpatient
15%
Development
14%
Tau
13%
Biological Marker
13%
Therapeutic Procedure
12%
Diagnosis
12%
Age
12%
Subthalamic Nucleus
12%
Parasympathomimetic Drug
12%
Association
12%
Drug
11%
Chemotherapeutic Agent
11%
Surgery
11%
Symptom
11%
Frontotemporal Lobar Degeneration
10%
COVID-19
10%
Pharmacogenetics
10%
Temporal Lobe Epilepsy
10%
Epigenomics
10%
Phenotype
10%
Analysis
9%
Zolpidem
9%
Disability
8%
Mortality
8%
Genotype
8%
Neuroimaging
8%
Gait
8%
Treatment of Parkinson's Disease
7%
Life
7%
Depression
7%
Spasticity
7%
Cohort Effect
7%
Late Life Depression
6%
Deterioration
6%
Cognitive Defect
6%
Neurologic Disease
6%
Gene
6%
Neuroscience
Parkinson's Disease
100%
Deep Brain Stimulation
45%
Subthalamic Nucleus
42%
Dementia
29%
Cognitive Disorders
27%
Genotype
26%
Brain
21%
Comprehension
21%
Frontotemporal Dementia
19%
Gene
19%
Polymorphism
17%
Apolipoprotein E
17%
Motor Cortex
17%
Cytochrome P450 2D6
14%
Vascular Dementia
12%
Progressive Supranuclear Palsy
11%
Gait
11%
Depression
11%
Cognition
11%
Phenotype
11%
Donepezil
10%
Mild Cognitive Impairment
10%
Temporal Lobe
9%
Behavior Disorder
9%
Tremor
7%
Coronavirus
7%
Primary Progressive Aphasia
6%
Anxiety
6%
Late Life Depression
6%
Promoter Region
6%
Stroke
6%
Hypersexuality
6%
Single-Photon Emission Computed Tomography
6%
Single-Nucleotide Polymorphism
5%
Bipolar Disorder
5%
Cholinergic
5%
Normal Pressure Hydrocephalus
5%
Traumatic Brain Injury
5%
Spinal Cord Stimulation
5%
Suicidal Ideation
5%
Eyelid Reflex
5%
Mood Disorder
5%
Spectrum Disorder
5%
Impulse Control Disorder
5%
Compulsive Behavior
5%
Hearing Loss
5%
Psychiatry
5%
Antidepressant
5%
Endophenotype
5%
Proteomics
5%
Pharmacology, Toxicology and Pharmaceutical Science
Alzheimer Disease
75%
Drug
36%
Frailty
30%
CYP2D6
25%
Diseases
23%
Tauopathy
15%
Depression
12%
Adverse Drug Reaction
11%
Dementia
10%
Parkinson Disease
10%
Spasticity
10%
Botulinum Toxin A
10%
Donepezil
10%
Bipolar Disorder
10%
Zolpidem
9%
Peptide
8%
Symptom
8%
Frontotemporal Dementia
7%
Amyloid
7%
Randomized Clinical Trial
7%
Prevalence
6%
Monoclonal Antibody
6%
Neurologic Disease
6%
Progressive Supranuclear Palsy
6%
Cytochrome P450
5%
Pharmacogenetics
5%
Multiinfarct Dementia
5%
Microflora
5%
Vitamin D
5%
Oligonucleotide
5%
Alzheimer's Disease
5%
Solanezumab
5%
Biological Marker
5%
Blood Group A Antibody
5%
